Histological and biochemical investigation of the renoprotective effects of metformin in diabetic and prostate cancer model.

Pinar Koroglu Aydin Bertan Boran Bayrak Ilknur Bugan Gul Omur Karabulut Bulan Refiye Yanardag

Published in: Toxicology mechanisms and methods (2021)

In conclusion, metformin treatment can be considered an adjuvant candidate for kidney tissue in diabetes, prostate cancer and cancer therapy related damage.

Keyphrases

prostate cancer
cancer therapy
radical prostatectomy
type diabetes
cardiovascular disease
drug delivery
oxidative stress
glycemic control
metabolic syndrome
wound healing
insulin resistance
skeletal muscle
adipose tissue
diabetic nephropathy